InsidersTradesSigma
Total declarations
Company
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Appelbaum Kevin J, Chief Executive Officer. Officer active across 1 company, notably Better Therapeutics, Inc.. Aggregated, 9 disclosures have been published. Breakdown: 9 buys · 0 sell. Total volume traded: €36k. Activity tracked since 2 December 2021. The latest transaction was disclosed on 31 March 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
2,500 shares@ US$1.968581.54% mcap12.5% of flowCommon StockSEC:0000899243-22-013342:0
Ideal exit: 26 Dec 2022 (T+270)
1,000 shares@ US$4.599975.05% mcap26.3% of flowCommon StockSEC:0000899243-21-049425
Ideal exit: 16 Sept 2022 (T+270)
1,000 shares@ US$4.599975.05% mcap11.5% of flowCommon StockSEC:0000899243-21-049425:0
Ideal exit: 16 Sept 2022 (T+270)
750 shares@ US$4.706557.50% mcap8.8% of flowCommon StockSEC:0000899243-21-048904:0
Ideal exit: 11 Sept 2022 (T+270)
750 shares@ US$4.706557.50% mcap20.2% of flowCommon StockSEC:0000899243-21-048904
Ideal exit: 11 Sept 2022 (T+270)
1,000 shares@ US$5.975297.06% mcap14.9% of flowCommon StockSEC:0000899243-21-048151:0
Ideal exit: 6 Sept 2022 (T+270)
1,000 shares@ US$5.975297.06% mcap34.1% of flowCommon StockSEC:0000899243-21-048151
Ideal exit: 6 Sept 2022 (T+270)
500 shares@ US$6.8455.43% mcap19.4% of flowCommon StockSEC:0000899243-21-046974
Ideal exit: 29 Aug 2022 (T+270)
500 shares@ US$6.8455.43% mcap8.5% of flowCommon StockSEC:0000899243-21-046974:0
Ideal exit: 29 Aug 2022 (T+270)
9 of 9 declarations
About Appelbaum Kevin J
Kevin J. Appelbaum is the Chief Executive Officer of Better Therapeutics, Inc. He leads the company in developing innovative therapeutic solutions. His role is crucial for the growth strategy and the company's impact on the healthcare market.
